Realta Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.6K Sell
514
-74
-13% -$6.14K 0.02% 237
2025
Q1
$47.7K Hold
588
0.02% 235
2024
Q4
$54.3K Sell
588
-51
-8% -$4.71K 0.02% 247
2024
Q3
$63.3K Sell
639
-3,488
-85% -$346K 0.03% 232
2024
Q2
$383K Sell
4,127
-810
-16% -$75.1K 0.07% 272
2024
Q1
$469K Sell
4,937
-330
-6% -$31.3K 0.1% 244
2023
Q4
$470K Sell
5,267
-840
-14% -$75K 0.11% 227
2023
Q3
$508K Buy
6,107
+100
+2% +$8.32K 0.12% 206
2023
Q2
$500K Sell
6,007
-210
-3% -$17.5K 0.11% 220
2023
Q1
$474K Sell
6,217
-2,255
-27% -$172K 0.12% 212
2022
Q4
$703K Hold
8,472
0.17% 138
2022
Q3
$672K Sell
8,472
-963
-10% -$76.4K 0.18% 146
2022
Q2
$722K Buy
9,435
+58
+0.6% +$4.44K 0.18% 133
2022
Q1
$843K Buy
9,377
+4,245
+83% +$382K 0.17% 134
2021
Q4
$575K Buy
5,132
+230
+5% +$25.8K 0.13% 190
2021
Q3
$616K Buy
4,902
+50
+1% +$6.28K 0.15% 176
2021
Q2
$657K Sell
4,852
-40
-0.8% -$5.42K 0.16% 164
2021
Q1
$664K Buy
4,892
+21
+0.4% +$2.85K 0.17% 151
2020
Q4
$686K Buy
4,871
+6
+0.1% +$845 0.19% 121
2020
Q3
$542K Sell
4,865
-135
-3% -$15K 0.18% 144
2020
Q2
$560K Buy
5,000
+275
+6% +$30.8K 0.18% 139
2020
Q1
$366K Buy
4,725
+641
+16% +$49.7K 0.16% 177
2019
Q4
$383K Buy
4,084
+373
+10% +$35K 0.1% 224
2019
Q3
$286K Buy
3,711
+470
+15% +$36.2K 0.08% 265
2019
Q2
$286K Buy
3,241
+1,229
+61% +$108K 0.08% 265
2019
Q1
$185K Buy
+2,012
New +$185K 0.08% 283